ABM HSA Mirna inhibitor

hsa miR miRNA Inhibitor ABM – Antibody-Antibodies

Background

Non-coding RNAs and significantly microRNAs have been discovered to behave as grasp regulators of most cancers initiation and growth. The intention of our analysis was to search out and characterize the carry out of however functionally uncharacterized microRNAs in human breast carcinogenesis.

miRNA inhibitors block miRNA regulation of objective gene expression by safe suppression and would possibly knock down native miRNA expression in cells. They are often utilized in miRNA loss-of-function analysis, miRNA objective web page identification and validation, and miRNA screening experiments. abm‘s Lentivirus miRNA Inhibitors allow for safe, long term expression of miRNA inhibitors out of your cell line.

Key Choices

  • We offer a gaggle of miRNA Inhibitors for knockdown of over 5000 miRNAs from human, mouse, and rat.
  • Lentiviral provide for integration of genetic supplies into host cells, inflicting safe, long term gene expression.
  • Lentivirus has a broad host fluctuate and would possibly infect every dividing and non-dividing cells, allowing gene provide to all types of cell types.

For gene regulation and helpful analysis, abm presents a variety of expression strategies for:

  1. siRNA: successfully categorical any objective siRNA to knockdown any gene with out the need to design hair-pin loop shRNA constructions, obtainable in lentivirus, AAV and Adenovirus.
  2. miRNA: inhibit or over-express any miRNA for analysis of post-transcriptional gene regulation in mammalian strategies using our ready-to-use viral vectors and packaged viruses, along with our detection and quantification devices.
  3. UTR Reporters: quantitatively analysis a selected miRNA’s regulation of its objective gene using our 3’UTR or 5’UTR platform, all obtainable as a library of premade lentiviral vectors and lentiviruses for any human, mouse or rat gene.
abm hsa mirna inhibitor
abm hsa mirna inhibitor

Methods

In an unbiased technique, we utilized a longtime model system for breast most cancers (BC) stem cell formation (“mammosphere assay”) to ascertain full miRNome alterations in breast carcinogenesis. Medical samples of BC victims had been used to evaluate the human relevance of the newly acknowledged miRNA candidates. One promising candidate, miR-1287-5p, was extra explored on its impression on plenty of hallmarks of most cancers. The molecular mode of movement was characterised by full transcriptome analysis, in silico prediction devices, miRNA-interaction assays, pheno-copy assays, and drug sensitivity assays.

hsa-let-7c miRNA Inhibitor

MIH01007 2 x 5.0 nmol
EUR 176

hsa-let-7d miRNA Inhibitor

MIH01010 2 x 5.0 nmol
EUR 176

hsa-let-7e miRNA Inhibitor

MIH01013 2 x 5.0 nmol
EUR 176

hsa-let-7g miRNA Inhibitor

MIH01020 2 x 5.0 nmol
EUR 176

hsa-let-7i miRNA Inhibitor

MIH01023 2 x 5.0 nmol
EUR 176

hsa-miR-1 miRNA Inhibitor

MIH01026 2 x 5.0 nmol
EUR 176

hsa-miR-100 miRNA Inhibitor

MIH01027 2 x 5.0 nmol
EUR 176

hsa-miR-101 miRNA Inhibitor

MIH01030 2 x 5.0 nmol
EUR 176

hsa-miR-103 miRNA Inhibitor

MIH01033 2 x 5.0 nmol
EUR 176

hsa-miR-103b miRNA Inhibitor

MIH01037 2 x 5.0 nmol
EUR 176

hsa-miR-105 miRNA Inhibitor

MIH01038 2 x 5.0 nmol
EUR 176

hsa-miR-106a miRNA Inhibitor

MIH01041 2 x 5.0 nmol
EUR 176

hsa-miR-106b miRNA Inhibitor

MIH01044 2 x 5.0 nmol
EUR 176

hsa-miR-107 miRNA Inhibitor

MIH01047 2 x 5.0 nmol
EUR 176

hsa-miR-10a miRNA Inhibitor

MIH01048 2 x 5.0 nmol
EUR 176

hsa-miR-10b miRNA Inhibitor

MIH01051 2 x 5.0 nmol
EUR 176

hsa-miR-1178 miRNA Inhibitor

MIH01054 2 x 5.0 nmol
EUR 176

hsa-miR-1179 miRNA Inhibitor

MIH01057 2 x 5.0 nmol
EUR 176

hsa-miR-1180 miRNA Inhibitor

MIH01058 2 x 5.0 nmol
EUR 176

hsa-miR-1181 miRNA Inhibitor

MIH01061 2 x 5.0 nmol
EUR 176

Leave a Comment

Your email address will not be published.